APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

MET TKIs

Compare research editions
View pricing & licenses

Selected research

Industry Research

MET TKIs Industry Research Report 2026

Report ID 174012390527 December 2025132 pages

Choose your research edition.

Industry ResearchMET TKIs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal MET TKIs Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal MET TKIs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal MET TKIs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global MET TKIs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for MET TKIs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for MET TKIs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of MET TKIs include Wanbang Biopharmaceuticals, CSPC Pharmaceutical, Asymchem, Shanghai Hutchison Pharmaceuticals, WuXi STA, Haihe Biopharma, Avistone Pharmaceuticals Biotechnology, Zydus and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global MET TKIs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

MET TKIs Market by Company

Wanbang Biopharmaceuticals

CSPC Pharmaceutical

Asymchem

Shanghai Hutchison Pharmaceuticals

WuXi STA

Haihe Biopharma

Avistone Pharmaceuticals Biotechnology

Zydus

Teva

Pfizer

Novartis

Merck

Genvio Pharma

Exelixis

Everest Pharmaceuticals

Drug International

Cipla

Beacom

BDR Pharma

MET TKIs Segment by Type

Multi-target Inhibitors

Single-target Inhibitors

MET TKIs Segment by Application

Non-small Cell Lung Cancer

Medullary Thyroid Cancer

Other

MET TKIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MET TKIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of MET TKIs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of MET TKIs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of MET TKIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global MET TKIs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global MET TKIs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global MET TKIs Sales Market Share by Manufacturers (2021-2026) Table 8. Global MET TKIs Revenue of Manufacturers (2021-2026) Table 9. Global MET TKIs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market MET TKIs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global MET TKIs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of MET TKIs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of MET TKIs, Product Type & Application Table 14. Global MET TKIs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global MET TKIs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Wanbang Biopharmaceuticals Company Information Table 19. Wanbang Biopharmaceuticals Business Overview Table 20. Wanbang Biopharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Wanbang Biopharmaceuticals MET TKIs Product Portfolio Table 22. Wanbang Biopharmaceuticals Recent Developments Table 23. CSPC Pharmaceutical Company Information Table 24. CSPC Pharmaceutical Business Overview Table 25. CSPC Pharmaceutical MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. CSPC Pharmaceutical MET TKIs Product Portfolio Table 27. CSPC Pharmaceutical Recent Developments Table 28. Asymchem Company Information Table 29. Asymchem Business Overview Table 30. Asymchem MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Asymchem MET TKIs Product Portfolio Table 32. Asymchem Recent Developments Table 33. Shanghai Hutchison Pharmaceuticals Company Information Table 34. Shanghai Hutchison Pharmaceuticals Business Overview Table 35. Shanghai Hutchison Pharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio Table 37. Shanghai Hutchison Pharmaceuticals Recent Developments Table 38. WuXi STA Company Information Table 39. WuXi STA Business Overview Table 40. WuXi STA MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. WuXi STA MET TKIs Product Portfolio Table 42. WuXi STA Recent Developments Table 43. Haihe Biopharma Company Information Table 44. Haihe Biopharma Business Overview Table 45. Haihe Biopharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Haihe Biopharma MET TKIs Product Portfolio Table 47. Haihe Biopharma Recent Developments Table 48. Avistone Pharmaceuticals Biotechnology Company Information Table 49. Avistone Pharmaceuticals Biotechnology Business Overview Table 50. Avistone Pharmaceuticals Biotechnology MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio Table 52. Avistone Pharmaceuticals Biotechnology Recent Developments Table 53. Zydus Company Information Table 54. Zydus Business Overview Table 55. Zydus MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Zydus MET TKIs Product Portfolio Table 57. Zydus Recent Developments Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Teva MET TKIs Product Portfolio Table 62. Teva Recent Developments Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Pfizer MET TKIs Product Portfolio Table 67. Pfizer Recent Developments Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis MET TKIs Product Portfolio Table 72. Novartis Recent Developments Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck MET TKIs Product Portfolio Table 77. Merck Recent Developments Table 78. Genvio Pharma Company Information Table 79. Genvio Pharma Business Overview Table 80. Genvio Pharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Genvio Pharma MET TKIs Product Portfolio Table 82. Genvio Pharma Recent Developments Table 83. Exelixis Company Information Table 84. Exelixis Business Overview Table 85. Exelixis MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Exelixis MET TKIs Product Portfolio Table 87. Exelixis Recent Developments Table 88. Everest Pharmaceuticals Company Information Table 89. Everest Pharmaceuticals Business Overview Table 90. Everest Pharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Everest Pharmaceuticals MET TKIs Product Portfolio Table 92. Everest Pharmaceuticals Recent Developments Table 93. Drug International Company Information Table 94. Drug International Business Overview Table 95. Drug International MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Drug International MET TKIs Product Portfolio Table 97. Drug International Recent Developments Table 98. Cipla Company Information Table 99. Cipla Business Overview Table 100. Cipla MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Cipla MET TKIs Product Portfolio Table 102. Cipla Recent Developments Table 103. Beacom Company Information Table 104. Beacom Business Overview Table 105. Beacom MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Beacom MET TKIs Product Portfolio Table 107. Beacom Recent Developments Table 108. BDR Pharma Company Information Table 109. BDR Pharma Business Overview Table 110. BDR Pharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. BDR Pharma MET TKIs Product Portfolio Table 112. BDR Pharma Recent Developments Table 113. Global MET TKIs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global MET TKIs Sales by Region (2021-2026) & (K Units) Table 115. Global MET TKIs Sales Market Share by Region (2021-2026) Table 116. Global MET TKIs Sales by Region (2027-2032) & (K Units) Table 117. Global MET TKIs Sales Market Share by Region (2027-2032) Table 118. Global MET TKIs Revenue by Region (2021-2026) & (US$ Million) Table 119. Global MET TKIs Revenue Market Share by Region (2021-2026) Table 120. Global MET TKIs Revenue by Region (2027-2032) & (US$ Million) Table 121. Global MET TKIs Revenue Market Share by Region (2027-2032) Table 122. North America MET TKIs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America MET TKIs Sales by Country (2021-2026) & (K Units) Table 124. North America MET TKIs Sales by Country (2027-2032) & (K Units) Table 125. North America MET TKIs Revenue by Country (2021-2026) & (US$ Million) Table 126. North America MET TKIs Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe MET TKIs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe MET TKIs Sales by Country (2021-2026) & (K Units) Table 129. Europe MET TKIs Sales by Country (2027-2032) & (K Units) Table 130. Europe MET TKIs Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe MET TKIs Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific MET TKIs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific MET TKIs Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific MET TKIs Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific MET TKIs Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific MET TKIs Revenue by Country (2027-2032) & (US$ Million) Table 137. South America MET TKIs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America MET TKIs Sales by Country (2021-2026) & (K Units) Table 139. South America MET TKIs Sales by Country (2027-2032) & (K Units) Table 140. South America MET TKIs Revenue by Country (2021-2026) & (US$ Million) Table 141. South America MET TKIs Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa MET TKIs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa MET TKIs Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa MET TKIs Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa MET TKIs Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa MET TKIs Revenue by Country (2027-2032) & (US$ Million) Table 147. Global MET TKIs Sales by Type (2021-2026) & (K Units) Table 148. Global MET TKIs Sales by Type (2027-2032) & (K Units) Table 149. Global MET TKIs Sales Market Share by Type (2021-2026) Table 150. Global MET TKIs Sales Market Share by Type (2027-2032) Table 151. Global MET TKIs Revenue by Type (2021-2026) & (US$ Million) Table 152. Global MET TKIs Revenue by Type (2027-2032) & (US$ Million) Table 153. Global MET TKIs Revenue Market Share by Type (2021-2026) Table 154. Global MET TKIs Revenue Market Share by Type (2027-2032) Table 155. Global MET TKIs Price by Type (2021-2026) & (US$/Unit) Table 156. Global MET TKIs Price by Type (2027-2032) & (US$/Unit) Table 157. Global MET TKIs Sales by Application (2021-2026) & (K Units) Table 158. Global MET TKIs Sales by Application (2027-2032) & (K Units) Table 159. Global MET TKIs Sales Market Share by Application (2021-2026) Table 160. Global MET TKIs Sales Market Share by Application (2027-2032) Table 161. Global MET TKIs Revenue by Application (2021-2026) & (US$ Million) Table 162. Global MET TKIs Revenue by Application (2027-2032) & (US$ Million) Table 163. Global MET TKIs Revenue Market Share by Application (2021-2026) Table 164. Global MET TKIs Revenue Market Share by Application (2027-2032) Table 165. Global MET TKIs Price by Application (2021-2026) & (US$/Unit) Table 166. Global MET TKIs Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. MET TKIs Distributors List Table 170. MET TKIs Customers List Table 171. MET TKIs Industry Trends Table 172. MET TKIs Industry Drivers Table 173. MET TKIs Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. MET TKIs Product Image Figure 5. Global MET TKIs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global MET TKIs Market Size (2021-2032) & (US$ Million) Figure 7. Global MET TKIs Sales (2021-2032) & (K Units) Figure 8. Global MET TKIs Average Price (US$/Unit) & (2021-2032) Figure 9. Multi-target Inhibitors Product Image Figure 10. Single-target Inhibitors Product Image Figure 11. Non-small Cell Lung Cancer Product Image Figure 12. Medullary Thyroid Cancer Product Image Figure 13. Other Product Image Figure 14. Global MET TKIs Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of MET TKIs, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 MET TKIs Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global MET TKIs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global MET TKIs Sales by Region in 2025 Figure 20. Global MET TKIs Revenue by Region in 2025 Figure 21. North America MET TKIs Market Size by Country in 2025 Figure 22. North America MET TKIs Sales Market Share by Country (2021-2032) Figure 23. North America MET TKIs Revenue Market Share by Country (2021-2032) Figure 24. United States MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe MET TKIs Market Size by Country in 2025 Figure 28. Europe MET TKIs Sales Market Share by Country (2021-2032) Figure 29. Europe MET TKIs Revenue Market Share by Country (2021-2032) Figure 30. Germany MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific MET TKIs Market Size by Country in 2025 Figure 41. Asia Pacific MET TKIs Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific MET TKIs Revenue Market Share by Country (2021-2032) Figure 43. China MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America MET TKIs Market Size by Country in 2025 Figure 52. South America MET TKIs Sales Market Share by Country (2021-2032) Figure 53. South America MET TKIs Revenue Market Share by Country (2021-2032) Figure 54. Brazil MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa MET TKIs Market Size by Country in 2025 Figure 59. Middle East and Africa MET TKIs Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa MET TKIs Revenue Market Share by Country (2021-2032) Figure 61. Egypt MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries MET TKIs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global MET TKIs Sales Market Share by Type (2021-2032) Figure 67. Global MET TKIs Revenue Market Share by Type (2021-2032) Figure 68. Global MET TKIs Price (US$/Unit) by Type (2021-2032) Figure 69. Global MET TKIs Sales Market Share by Application (2021-2032) Figure 70. Global MET TKIs Revenue Market Share by Application (2021-2032) Figure 71. Global MET TKIs Price (US$/Unit) by Application (2021-2032) Figure 72. MET TKIs Value Chain Figure 73. MET TKIs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. MET TKIs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Multi-target Inhibitors
  • Single-target Inhibitors
Applications
  • Non-small Cell Lung Cancer
  • Medullary Thyroid Cancer
  • Other
Companies covered
  • Wanbang Biopharmaceuticals
  • CSPC Pharmaceutical
  • Asymchem
  • Shanghai Hutchison Pharmaceuticals
  • WuXi STA
  • Haihe Biopharma
  • Avistone Pharmaceuticals Biotechnology
  • Zydus
  • Teva
  • Pfizer
  • Novartis
  • Merck
  • Genvio Pharma
  • Exelixis
  • Everest Pharmaceuticals
  • Drug International
  • Cipla
  • Beacom
  • BDR Pharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global MET TKIs Market Size (2021-2032)
  4. 2.2.2 Global MET TKIs Sales (2021-2032)
  5. 2.2.3 Global MET TKIs Market Average Price (2021-2032)
  6. 2.3 MET TKIs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Multi-target Inhibitors
  9. 2.3.3 Single-target Inhibitors
  10. 2.4 MET TKIs by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Non-small Cell Lung Cancer
  13. 2.4.3 Medullary Thyroid Cancer
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global MET TKIs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global MET TKIs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global MET TKIs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global MET TKIs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global MET TKIs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of MET TKIs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of MET TKIs, Product Type & Application
  8. 3.8 Global Manufacturers of MET TKIs, Established Date
  9. 3.9 Global MET TKIs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Wanbang Biopharmaceuticals
  2. 4.1.1 Wanbang Biopharmaceuticals Company Information
  3. 4.1.2 Wanbang Biopharmaceuticals Business Overview
  4. 4.1.3 Wanbang Biopharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Wanbang Biopharmaceuticals MET TKIs Product Portfolio
  6. 4.1.5 Wanbang Biopharmaceuticals Recent Developments
  7. 4.2 CSPC Pharmaceutical
  8. 4.2.1 CSPC Pharmaceutical Company Information
  9. 4.2.2 CSPC Pharmaceutical Business Overview
  10. 4.2.3 CSPC Pharmaceutical MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 CSPC Pharmaceutical MET TKIs Product Portfolio
  12. 4.2.5 CSPC Pharmaceutical Recent Developments
  13. 4.3 Asymchem
  14. 4.3.1 Asymchem Company Information
  15. 4.3.2 Asymchem Business Overview
  16. 4.3.3 Asymchem MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Asymchem MET TKIs Product Portfolio
  18. 4.3.5 Asymchem Recent Developments
  19. 4.4 Shanghai Hutchison Pharmaceuticals
  20. 4.4.1 Shanghai Hutchison Pharmaceuticals Company Information
  21. 4.4.2 Shanghai Hutchison Pharmaceuticals Business Overview
  22. 4.4.3 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio
  24. 4.4.5 Shanghai Hutchison Pharmaceuticals Recent Developments
  25. 4.5 WuXi STA
  26. 4.5.1 WuXi STA Company Information
  27. 4.5.2 WuXi STA Business Overview
  28. 4.5.3 WuXi STA MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 WuXi STA MET TKIs Product Portfolio
  30. 4.5.5 WuXi STA Recent Developments
  31. 4.6 Haihe Biopharma
  32. 4.6.1 Haihe Biopharma Company Information
  33. 4.6.2 Haihe Biopharma Business Overview
  34. 4.6.3 Haihe Biopharma MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Haihe Biopharma MET TKIs Product Portfolio
  36. 4.6.5 Haihe Biopharma Recent Developments
  37. 4.7 Avistone Pharmaceuticals Biotechnology
  38. 4.7.1 Avistone Pharmaceuticals Biotechnology Company Information
  39. 4.7.2 Avistone Pharmaceuticals Biotechnology Business Overview
  40. 4.7.3 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio
  42. 4.7.5 Avistone Pharmaceuticals Biotechnology Recent Developments
  43. 4.8 Zydus
  44. 4.8.1 Zydus Company Information
  45. 4.8.2 Zydus Business Overview
  46. 4.8.3 Zydus MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Zydus MET TKIs Product Portfolio
  48. 4.8.5 Zydus Recent Developments
  49. 4.9 Teva
  50. 4.9.1 Teva Company Information
  51. 4.9.2 Teva Business Overview
  52. 4.9.3 Teva MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Teva MET TKIs Product Portfolio
  54. 4.9.5 Teva Recent Developments
  55. 4.10 Pfizer
  56. 4.10.1 Pfizer Company Information
  57. 4.10.2 Pfizer Business Overview
  58. 4.10.3 Pfizer MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Pfizer MET TKIs Product Portfolio
  60. 4.10.5 Pfizer Recent Developments
  61. 4.11 Novartis
  62. 4.11.1 Novartis Company Information
  63. 4.11.2 Novartis Business Overview
  64. 4.11.3 Novartis MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Novartis MET TKIs Product Portfolio
  66. 4.11.5 Novartis Recent Developments
  67. 4.12 Merck
  68. 4.12.1 Merck Company Information
  69. 4.12.2 Merck Business Overview
  70. 4.12.3 Merck MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Merck MET TKIs Product Portfolio
  72. 4.12.5 Merck Recent Developments
  73. 4.13 Genvio Pharma
  74. 4.13.1 Genvio Pharma Company Information
  75. 4.13.2 Genvio Pharma Business Overview
  76. 4.13.3 Genvio Pharma MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Genvio Pharma MET TKIs Product Portfolio
  78. 4.13.5 Genvio Pharma Recent Developments
  79. 4.14 Exelixis
  80. 4.14.1 Exelixis Company Information
  81. 4.14.2 Exelixis Business Overview
  82. 4.14.3 Exelixis MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Exelixis MET TKIs Product Portfolio
  84. 4.14.5 Exelixis Recent Developments
  85. 4.15 Everest Pharmaceuticals
  86. 4.15.1 Everest Pharmaceuticals Company Information
  87. 4.15.2 Everest Pharmaceuticals Business Overview
  88. 4.15.3 Everest Pharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Everest Pharmaceuticals MET TKIs Product Portfolio
  90. 4.15.5 Everest Pharmaceuticals Recent Developments
  91. 4.16 Drug International
  92. 4.16.1 Drug International Company Information
  93. 4.16.2 Drug International Business Overview
  94. 4.16.3 Drug International MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Drug International MET TKIs Product Portfolio
  96. 4.16.5 Drug International Recent Developments
  97. 4.17 Cipla
  98. 4.17.1 Cipla Company Information
  99. 4.17.2 Cipla Business Overview
  100. 4.17.3 Cipla MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Cipla MET TKIs Product Portfolio
  102. 4.17.5 Cipla Recent Developments
  103. 4.18 Beacom
  104. 4.18.1 Beacom Company Information
  105. 4.18.2 Beacom Business Overview
  106. 4.18.3 Beacom MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Beacom MET TKIs Product Portfolio
  108. 4.18.5 Beacom Recent Developments
  109. 4.19 BDR Pharma
  110. 4.19.1 BDR Pharma Company Information
  111. 4.19.2 BDR Pharma Business Overview
  112. 4.19.3 BDR Pharma MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 BDR Pharma MET TKIs Product Portfolio
  114. 4.19.5 BDR Pharma Recent Developments
5 Global MET TKIs Market Scenario by Region
  1. 5.1 Global MET TKIs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global MET TKIs Sales by Region: 2021-2032
  3. 5.2.1 Global MET TKIs Sales by Region: 2021-2026
  4. 5.2.2 Global MET TKIs Sales by Region: 2027-2032
  5. 5.3 Global MET TKIs Revenue by Region: 2021-2032
  6. 5.3.1 Global MET TKIs Revenue by Region: 2021-2026
  7. 5.3.2 Global MET TKIs Revenue by Region: 2027-2032
  8. 5.4 North America MET TKIs Market Facts & Figures by Country
  9. 5.4.1 North America MET TKIs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America MET TKIs Sales by Country (2021-2032)
  11. 5.4.3 North America MET TKIs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe MET TKIs Market Facts & Figures by Country
  16. 5.5.1 Europe MET TKIs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe MET TKIs Sales by Country (2021-2032)
  18. 5.5.3 Europe MET TKIs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific MET TKIs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific MET TKIs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific MET TKIs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific MET TKIs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America MET TKIs Market Facts & Figures by Country
  41. 5.7.1 South America MET TKIs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America MET TKIs Sales by Country (2021-2032)
  43. 5.7.3 South America MET TKIs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa MET TKIs Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa MET TKIs Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa MET TKIs Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa MET TKIs Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global MET TKIs Sales by Type (2021-2032)
  2. 6.1.1 Global MET TKIs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global MET TKIs Sales Market Share by Type (2021-2032)
  4. 6.2 Global MET TKIs Revenue by Type (2021-2032)
  5. 6.2.1 Global MET TKIs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global MET TKIs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global MET TKIs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global MET TKIs Sales by Application (2021-2032)
  2. 7.1.1 Global MET TKIs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global MET TKIs Sales Market Share by Application (2021-2032)
  4. 7.2 Global MET TKIs Revenue by Application (2021-2032)
  5. 7.2.1 Global MET TKIs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global MET TKIs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global MET TKIs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 MET TKIs Value Chain Analysis
  2. 8.1.1 MET TKIs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 MET TKIs Production Mode & Process
  5. 8.2 MET TKIs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 MET TKIs Distributors
  8. 8.2.3 MET TKIs Customers
9 Global MET TKIs Analyzing Market Dynamics
  1. 9.1 MET TKIs Industry Trends
  2. 9.2 MET TKIs Industry Drivers
  3. 9.3 MET TKIs Industry Opportunities and Challenges
  4. 9.4 MET TKIs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst